H Malluche, MC Faugere - Kidney Int, 1990 - nature.com Kidney International aims to inform the renal researcher and practicing nephrologists
on all aspects of renal research. Clinical and basic renal research, commentaries ... Cited by 257 - Related articles - All 3 versions
- ►pasteur.ac.ir [PDF] PJ Kostenuik - Current Opinion in Pharmacology, 2005 - Elsevier Osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand
(RANKL) are dominant regulators of bone resorption. Many hormones, cytokines and
growth factors mediate bone resorption by altering the ratio of RANKL to ... Cited by 80 - Related articles - All 4 versions
R Weberg, A Berstad - Eur J Clin Invest, 1986 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 76 - Related articles - All 2 versions
WG Goodman, DA Henry, R Horst, RK … - Kidney int, 1984 - nature.com Parenteral aluminum administration in the dog: II. Induction of osteomalacia and
effect on vitamin D metabolism. There is an association between bone aluminum
(Al) accumulation and dialysis-associated osteomalacia (OM). To study ... Cited by 69 - Related articles - All 3 versions
- ►ajcn.org [PDF] M Shike, ME Shils, A Heller, N Alcock, V … - American Journal of Clinical Nutrition, 1986 - Am Soc Nutrition A metabolic bone disease has been reported (1-5) in patients receiving long-term
total parenteral nutrition (TPN). The features of the bone disease include
hypercalcemia, excessive losses of calcium and phosphorus in the urine, ... Cited by 62 - Related articles - All 6 versions
